Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42


Real-Time PCR Method for Detection of Salmonella spp. in Environmental Samples.

Kasturi KN, Drgon T.

Appl Environ Microbiol. 2017 Jun 30;83(14). pii: e00644-17. doi: 10.1128/AEM.00644-17. Print 2017 Jul 15.


Functional consequences of 17q21.31/WNT3-WNT9B amplification in hPSCs with respect to neural differentiation.

Lee CT, Bendriem RM, Kindberg AA, Worden LT, Williams MP, Drgon T, Mallon BS, Harvey BK, Richie CT, Hamilton RS, Chen J, Errico SL, Tsai SY, Uhl GR, Freed WJ.

Cell Rep. 2015 Feb 3;10(4):616-32. doi: 10.1016/j.celrep.2014.12.050. Epub 2015 Jan 29.


Genomic regions identified by overlapping clusters of nominally-positive SNPs from genome-wide studies of alcohol and illegal substance dependence.

Johnson C, Drgon T, Walther D, Uhl GR.

PLoS One. 2011;6(7):e19210. doi: 10.1371/journal.pone.0019210. Epub 2011 Jul 27.


"Replicated" genome wide association for dependence on illegal substances: genomic regions identified by overlapping clusters of nominally positive SNPs.

Drgon T, Johnson CA, Nino M, Drgonova J, Walther DM, Uhl GR.

Am J Med Genet B Neuropsychiatr Genet. 2011 Mar;156(2):125-38. doi: 10.1002/ajmg.b.31143. Epub 2010 Dec 16.


Genome-wide association for smoking cessation success in a trial of precessation nicotine replacement.

Uhl GR, Drgon T, Johnson C, Ramoni MF, Behm FM, Rose JE.

Mol Med. 2010 Nov-Dec;16(11-12):513-26. doi: 10.2119/molmed.2010.00052. Epub 2010 Aug 24.


Personalized smoking cessation: interactions between nicotine dose, dependence and quit-success genotype score.

Rose JE, Behm FM, Drgon T, Johnson C, Uhl GR.

Mol Med. 2010 Jul-Aug;16(7-8):247-53. doi: 10.2119/molmed.2009.00159. Epub 2010 Mar 17. Erratum in: Mol Med. 2012;18(1):729.


Genome-wide association for smoking cessation success: participants in the Patch in Practice trial of nicotine replacement.

Uhl GR, Drgon T, Johnson C, Walther D, David SP, Aveyard P, Murphy M, Johnstone EC, Munafò MR.

Pharmacogenomics. 2010 Mar;11(3):357-67. doi: 10.2217/pgs.09.156. Erratum in: Pharmacogenomics. 2010 May;11(5):730. David, Sean P [Added].


Genome wide association for addiction: replicated results and comparisons of two analytic approaches.

Drgon T, Zhang PW, Johnson C, Walther D, Hess J, Nino M, Uhl GR.

PLoS One. 2010 Jan 21;5(1):e8832. doi: 10.1371/journal.pone.0008832.


Genome-wide association for smoking cessation success: participants in a trial with adjunctive denicotinized cigarettes.

Drgon T, Johnson C, Walther D, Albino AP, Rose JE, Uhl GR.

Mol Med. 2009 Jul-Aug;15(7-8):268-74. doi: 10.2119/molmed.2009.00040. Epub 2009 Apr 29.


Smoking and smoking cessation in disadvantaged women: assessing genetic contributions.

Uhl GR, Drgon T, Li CY, Johnson C, Liu QR.

Drug Alcohol Depend. 2009 Oct 1;104 Suppl 1:S58-63. doi: 10.1016/j.drugalcdep.2009.03.012. Epub 2009 May 12. Review.


Addiction genetics and pleiotropic effects of common haplotypes that make polygenic contributions to vulnerability to substance dependence.

Uhl GR, Drgon T, Johnson C, Liu QR.

J Neurogenet. 2009;23(3):272-82. doi: 10.1080/01677060802572929. Epub 2009 Jan 19. Review.


Convergent genome wide association results for bipolar disorder and substance dependence.

Johnson C, Drgon T, McMahon FJ, Uhl GR.

Am J Med Genet B Neuropsychiatr Genet. 2009 Mar 5;150B(2):182-90. doi: 10.1002/ajmg.b.30900.


Genome wide association for substance dependence: convergent results from epidemiologic and research volunteer samples.

Johnson C, Drgon T, Liu QR, Zhang PW, Walther D, Li CY, Anthony JC, Ding Y, Eaton WW, Uhl GR.

BMC Med Genet. 2008 Dec 18;9:113. doi: 10.1186/1471-2350-9-113.


Genome-wide association for nicotine dependence and smoking cessation success in NIH research volunteers.

Drgon T, Montoya I, Johnson C, Liu QR, Walther D, Hamer D, Uhl GR.

Mol Med. 2009 Jan-Feb;15(1-2):21-7. doi: 10.2119/molmed.2008.00096. Epub 2008 Oct 2.


Molecular genetics of addiction and related heritable phenotypes: genome-wide association approaches identify "connectivity constellation" and drug target genes with pleiotropic effects.

Uhl GR, Drgon T, Johnson C, Li CY, Contoreggi C, Hess J, Naiman D, Liu QR.

Ann N Y Acad Sci. 2008 Oct;1141:318-81. doi: 10.1196/annals.1441.018. Review.


Nicotine abstinence genotyping: assessing the impact on smoking cessation clinical trials.

Uhl GR, Drgon T, Johnson C, Rose JE.

Pharmacogenomics J. 2009 Apr;9(2):111-5. doi: 10.1038/tpj.2008.10. Epub 2008 Sep 9.


Molecular genetics of successful smoking cessation: convergent genome-wide association study results.

Uhl GR, Liu QR, Drgon T, Johnson C, Walther D, Rose JE, David SP, Niaura R, Lerman C.

Arch Gen Psychiatry. 2008 Jun;65(6):683-93. doi: 10.1001/archpsyc.65.6.683.


Hyperpolarized growth of Saccharomyces cerevisiae cak1P212S and cla4 mutants weakens cell walls and renders cells dependent on chitin synthase 3.

Schmidt M, Drgon T, Bowers B, Cabib E.

FEMS Yeast Res. 2008 May;8(3):362-73. doi: 10.1111/j.1567-1364.2008.00368.x. Epub 2008 Mar 27.


Genome-wide association for methamphetamine dependence: convergent results from 2 samples.

Uhl GR, Drgon T, Liu QR, Johnson C, Walther D, Komiyama T, Harano M, Sekine Y, Inada T, Ozaki N, Iyo M, Iwata N, Yamada M, Sora I, Chen CK, Liu HC, Ujike H, Lin SK.

Arch Gen Psychiatry. 2008 Mar;65(3):345-55. doi: 10.1001/archpsyc.65.3.345.


Neurexin 3 polymorphisms are associated with alcohol dependence and altered expression of specific isoforms.

Hishimoto A, Liu QR, Drgon T, Pletnikova O, Walther D, Zhu XG, Troncoso JC, Uhl GR.

Hum Mol Genet. 2007 Dec 1;16(23):2880-91. Epub 2007 Sep 4.


"Higher order" addiction molecular genetics: convergent data from genome-wide association in humans and mice.

Uhl GR, Drgon T, Johnson C, Fatusin OO, Liu QR, Contoreggi C, Li CY, Buck K, Crabbe J.

Biochem Pharmacol. 2008 Jan 1;75(1):98-111. Epub 2007 Jul 25. Review.


Effect of biotic and abiotic factors on in vitro proliferation, encystment, and excystment of Pfiesteria piscicida.

Saito K, Drgon T, Krupatkina DN, Drgonova J, Terlizzi DE, Mercer N, Vasta GR.

Appl Environ Microbiol. 2007 Oct;73(20):6410-20. Epub 2007 Aug 17.


Molecular genetics of nicotine dependence and abstinence: whole genome association using 520,000 SNPs.

Uhl GR, Liu QR, Drgon T, Johnson C, Walther D, Rose JE.

BMC Genet. 2007 Apr 3;8:10.


Addiction molecular genetics: 639,401 SNP whole genome association identifies many "cell adhesion" genes.

Liu QR, Drgon T, Johnson C, Walther D, Hess J, Uhl GR.

Am J Med Genet B Neuropsychiatr Genet. 2006 Dec 5;141B(8):918-25.


Common human 5' dopamine transporter (SLC6A3) haplotypes yield varying expression levels in vivo.

Drgon T, Lin Z, Wang GJ, Fowler J, Pablo J, Mash DC, Volkow N, Uhl GR.

Cell Mol Neurobiol. 2006 Jul-Aug;26(4-6):875-89. Epub 2006 May 20.


Pooled association genome scanning: validation and use to identify addiction vulnerability loci in two samples.

Liu QR, Drgon T, Walther D, Johnson C, Poleskaya O, Hess J, Uhl GR.

Proc Natl Acad Sci U S A. 2005 Aug 16;102(33):11864-9. Epub 2005 Aug 9.


SLC18A2 promoter haplotypes and identification of a novel protective factor against alcoholism.

Lin Z, Walther D, Yu XY, Li S, Drgon T, Uhl GR.

Hum Mol Genet. 2005 May 15;14(10):1393-404. Epub 2005 Apr 13.


Human brain derived neurotrophic factor (BDNF) genes, splicing patterns, and assessments of associations with substance abuse and Parkinson's Disease.

Liu QR, Walther D, Drgon T, Polesskaya O, Lesnick TG, Strain KJ, de Andrade M, Bower JH, Maraganore DM, Uhl GR.

Am J Med Genet B Neuropsychiatr Genet. 2005 Apr 5;134B(1):93-103.


Characterization of ichthyocidal activity of Pfiesteria piscicida: dependence on the dinospore cell density.

Drgon T, Saito K, Gillevet PM, Sikaroodi M, Whitaker B, Krupatkina DN, Argemi F, Vasta GR.

Appl Environ Microbiol. 2005 Jan;71(1):519-29.


The human serotonin receptor 2B: coding region polymorphisms and association with vulnerability to illegal drug abuse.

Lin Z, Walther D, Yu XY, Drgon T, Uhl GR.

Pharmacogenetics. 2004 Dec;14(12):805-11.


Septins, under Cla4p regulation, and the chitin ring are required for neck integrity in budding yeast.

Schmidt M, Varma A, Drgon T, Bowers B, Cabib E.

Mol Biol Cell. 2003 May;14(5):2128-41. Epub 2003 Feb 6.


Yeast cell permeabilization by osmotic shock allows determination of enzymatic activities in situ.

Crotti LB, Drgon T, Cabib E.

Anal Biochem. 2001 May 1;292(1):8-16.


The GTP-binding protein Rho1p is required for cell cycle progression and polarization of the yeast cell.

Drgonová J, Drgon T, Roh DH, Cabib E.

J Cell Biol. 1999 Jul 26;146(2):373-87.


Role of small G proteins in yeast cell polarization and wall biosynthesis.

Cabib E, Drgonová J, Drgon T.

Annu Rev Biochem. 1998;67:307-33. Review.


The yeast cell wall, a dynamic structure engaged in growth and morphogenesis.

Cabib E, Drgon T, Drgonová J, Ford RA, Kollár R.

Biochem Soc Trans. 1997 Feb;25(1):200-4. Review. No abstract available.


Rho1p, a yeast protein at the interface between cell polarization and morphogenesis.

Drgonová J, Drgon T, Tanaka K, Kollár R, Chen GC, Ford RA, Chan CS, Takai Y, Cabib E.

Science. 1996 Apr 12;272(5259):277-9.


Activity of the mitochondrial multiple conductance channel is independent of the adenine nucleotide translocator.

Lohret TA, Murphy RC, Drgoñ T, Kinnally KW.

J Biol Chem. 1996 Mar 1;271(9):4846-9.


ADP/ATP translocator is essential only for anaerobic growth of yeast Saccharomyces cerevisiae.

Drgon T, Sabová L, Nelson N, Kolarov J.

FEBS Lett. 1991 Sep 9;289(2):159-62.

Supplemental Content

Support Center